tailieunhanh - Health and Quality of Life Outcomes BioMed Central Review Open Access Quality of life in patients

Health and Quality of Life Outcomes BioMed Central Review Open Access Quality of life in patients with coronary heart disease-I: Assessment tools David R Thompson1 and Cheuk-Man Yu*2 Address: 1School of Nursing, The Chinese University of Hong Kong, Hong Kong and 2Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Email: David R Thompson - davidthompson@; Cheuk-Man Yu* - cmyu@ * Corresponding author Published: 10 September 2003 Health and Quality of Life Outcomes 2003, 1:42 This article is available from: Received: 29 July 2003 Accepted: 10 September 2003 © 2003 Thompson and Yu; licensee BioMed Central Ltd | BioMed Central Health and Quality of Life Outcomes Review Open Access Quality of life in patients with coronary heart disease-I Assessment tools David R Thompson1 and Cheuk-Man Yu 2 Address 1School of Nursing The Chinese University of Hong Kong Hong Kong and 2Division of Cardiology Department of Medicine and Therapeutics Prince of Wales Hospital The Chinese University of Hong Kong Hong Kong Email David RThompson - davidthompson@ Cheuk-Man Yu - cmyu@ Corresponding author Published 10 September 2003 Received 29 July 2003 Accepted 10 September 2003 Health and Quality of Life Outcomes 2003 1 42 This article is available from http content 1 1 42 2003 Thompson and Yu licensee BioMed Central Ltd. This is an Open Access article verbatim copying and redistribution of this article are permitted in all media for any purpose provided this notice is preserved along with the article s original URL. Abstract Health-related quality of life HRQL assessment is an important measure of the impact of the disease effect of treatment and other variables affecting people s lives. The review focused on the assessment of HRQL in patient with coronary heart disease CHD by appropriate tools. Although no consensus exists about the precise definition of HRQL a plethora of instruments have been developed to assess it. Two broad types - generic and disease-specific - have been developed but there is some debate about their relative merits. There is a wide selection of instruments available but choice should be based on a careful consideration of an instrument s psychometric properties the breadth and depth with which it addresses relevant health domains and the specific clinical or research purpose for which it is intended. Introduction There has been a rapid and significant growth in the measurement of quality of life as an indicator of health outcome in patients with coronary heart disease CHD . In the clinical course of CHD there are many aspects where .